CVS logo

CVS Health Corporation (CVS) Cash and cash equivalents

annual cash & cash equivalents:

$11.09B-$457.00M(-3.96%)
December 31, 2024

Summary

  • As of today (September 1, 2025), CVS annual cash & cash equivalents is $11.09 billion, with the most recent change of -$457.00 million (-3.96%) on December 31, 2024.
  • During the last 3 years, CVS annual cash & cash equivalents has fallen by -$4.50 billion (-28.88%).
  • CVS annual cash & cash equivalents is now -30.12% below its all-time high of $15.87 billion, reached on December 31, 2022.

Performance

CVS Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVSbalance sheet metrics

quarterly cash & cash equivalents:

$14.22B+$1.50B(+11.77%)
June 30, 2025

Summary

  • As of today (September 1, 2025), CVS quarterly cash & cash equivalents is $14.22 billion, with the most recent change of +$1.50 billion (+11.77%) on June 30, 2025.
  • Over the past year, CVS quarterly cash & cash equivalents has dropped by -$2.10 billion (-12.87%).
  • CVS quarterly cash & cash equivalents is now -67.64% below its all-time high of $43.92 billion, reached on June 30, 2018.

Performance

CVS quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVSbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CVS Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.0%-12.9%
3 y3 years-28.9%-6.0%
5 y5 years+37.6%-18.6%

CVS Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-30.1%at low-29.4%+45.9%
5 y5-year-30.1%+37.6%-29.4%+61.8%
alltimeall time-30.1%+9880.8%-67.6%>+9999.0%

CVS Cash and cash equivalents History

DateAnnualQuarterly
Jun 2025
-
$14.22B(+11.8%)
Mar 2025
-
$12.72B(+14.7%)
Dec 2024
$11.09B(-4.0%)
$11.09B(+13.8%)
Sep 2024
-
$9.74B(-40.3%)
Jun 2024
-
$16.32B(+24.2%)
Mar 2024
-
$13.14B(+13.8%)
Dec 2023
$11.54B(-27.2%)
$11.54B(-29.1%)
Sep 2023
-
$16.28B(-4.1%)
Jun 2023
-
$16.97B(-4.8%)
Mar 2023
-
$17.83B(+12.4%)
Dec 2022
$15.87B(+1.8%)
$15.87B(-21.2%)
Sep 2022
-
$20.14B(+33.2%)
Jun 2022
-
$15.12B(+6.1%)
Mar 2022
-
$14.26B(-8.6%)
Dec 2021
$15.59B(+43.6%)
$15.59B(+21.4%)
Sep 2021
-
$12.84B(+26.8%)
Jun 2021
-
$10.13B(+15.2%)
Mar 2021
-
$8.79B(-19.0%)
Dec 2020
$10.85B(+34.7%)
$10.85B(-10.2%)
Sep 2020
-
$12.09B(-30.8%)
Jun 2020
-
$17.46B(+37.4%)
Mar 2020
-
$12.71B(+57.8%)
Dec 2019
$8.06B(+22.3%)
$8.06B(+6.9%)
Sep 2019
-
$7.53B(-11.7%)
Jun 2019
-
$8.53B(+2.4%)
Mar 2019
-
$8.33B(+26.4%)
Dec 2018
$6.59B(+261.7%)
$6.59B(-84.2%)
Sep 2018
-
$41.70B(-5.1%)
Jun 2018
-
$43.92B(+4.2%)
Mar 2018
-
$42.16B(+2215.0%)
Dec 2017
$1.82B(-47.3%)
$1.82B(-28.9%)
Sep 2017
-
$2.56B(+18.0%)
Jun 2017
-
$2.17B(-5.8%)
Mar 2017
-
$2.30B(-33.4%)
Dec 2016
$3.46B(+35.8%)
$3.46B(+52.8%)
Sep 2016
-
$2.26B(+87.5%)
Jun 2016
-
$1.21B(-35.2%)
Mar 2016
-
$1.86B(-26.8%)
Dec 2015
$2.55B(+1.3%)
$2.55B(-15.4%)
Sep 2015
-
$3.01B(+114.5%)
Jun 2015
-
$1.40B(-14.1%)
Mar 2015
-
$1.63B(-35.0%)
Dec 2014
$2.52B(-39.8%)
$2.52B(+107.9%)
Sep 2014
-
$1.21B(-29.3%)
Jun 2014
-
$1.71B(-39.9%)
Mar 2014
-
$2.85B(-31.8%)
Dec 2013
$4.18B(+202.7%)
$4.18B(+159.0%)
Sep 2013
-
$1.61B(+36.8%)
Jun 2013
-
$1.18B(-24.2%)
Mar 2013
-
$1.56B(+12.8%)
Dec 2012
$1.38B(-2.7%)
$1.38B(+11.5%)
Sep 2012
-
$1.24B(-32.3%)
Jun 2012
-
$1.83B(-17.5%)
Mar 2012
-
$2.22B(+56.3%)
Dec 2011
$1.42B(-0.9%)
$1.42B(-17.2%)
Sep 2011
-
$1.71B(-23.3%)
Jun 2011
-
$2.23B(+3.0%)
Mar 2011
-
$2.17B(+51.5%)
Dec 2010
$1.43B(+31.2%)
$1.43B(+45.6%)
Sep 2010
-
$983.00M(-11.5%)
Jun 2010
-
$1.11B(+5.7%)
Mar 2010
-
$1.05B(-3.7%)
Dec 2009
$1.09B(-19.3%)
$1.09B(-3.9%)
Sep 2009
-
$1.14B(-7.3%)
Jun 2009
-
$1.23B(+22.8%)
Mar 2009
-
$997.40M(-26.2%)
Dec 2008
$1.35B(+24.7%)
$1.35B(+5.5%)
Sep 2008
-
$1.28B(+108.3%)
Jun 2008
-
$615.70M(-24.7%)
Mar 2008
-
$818.20M(-24.5%)
Dec 2007
$1.08B
$1.08B(+43.7%)
DateAnnualQuarterly
Sep 2007
-
$754.60M(-19.4%)
Jun 2007
-
$935.80M(+26.8%)
Mar 2007
-
$738.20M(+39.1%)
Dec 2006
$530.70M(+3.4%)
$530.70M(+34.5%)
Sep 2006
-
$394.60M(-25.9%)
Jun 2006
-
$532.30M(+37.5%)
Mar 2006
-
$387.10M(-24.6%)
Dec 2005
$513.40M(+30.9%)
$513.40M(+39.4%)
Sep 2005
-
$368.20M(-11.1%)
Jun 2005
-
$414.10M(+27.9%)
Mar 2005
-
$323.80M(+77.4%)
Dec 2004
$392.30M(-53.5%)
-
Dec 2003
$843.20M(+20.4%)
-
Dec 2002
$700.40M(+196.4%)
-
Dec 2001
$236.30M(-29.9%)
-
Dec 2000
$337.30M(+46.7%)
-
Jun 2000
-
$182.50M(-22.9%)
Mar 2000
-
$236.60M(+39.3%)
Dec 1999
$230.00M(+27.2%)
-
Sep 1999
-
$169.90M(-26.9%)
Jun 1999
-
$232.30M(+69.8%)
Mar 1999
-
$136.80M(+9.1%)
Dec 1998
$180.80M(+7.3%)
-
Sep 1998
-
$125.40M(+102.3%)
Jun 1998
-
$62.00M(-44.7%)
Mar 1998
-
$112.20M(-41.7%)
Dec 1997
$168.50M(-72.1%)
$192.50M(+26.7%)
Sep 1997
-
$151.90M(+102.8%)
Jun 1997
-
$74.90M(-77.6%)
Mar 1997
-
$334.60M(-29.1%)
Dec 1996
$603.30M(+98.1%)
$471.80M(+427.2%)
Sep 1996
-
$89.50M(+8.7%)
Jun 1996
-
$82.30M(-8.6%)
Mar 1996
-
$90.00M(-30.6%)
Dec 1995
$304.58M(+174.2%)
$129.60M(+61.8%)
Sep 1995
-
$80.10M(-3.1%)
Jun 1995
-
$82.70M(-6.3%)
Mar 1995
-
$88.30M(-24.5%)
Dec 1994
-
$117.00M(+41.1%)
Sep 1994
-
$82.90M(+16.9%)
Jun 1994
-
$70.90M(-37.4%)
Mar 1994
-
$113.20M(+39.8%)
Dec 1993
-
$81.00M(-11.7%)
Sep 1993
-
$91.70M(+22.8%)
Jun 1993
-
$74.70M(-13.0%)
Mar 1993
-
$85.90M(-40.8%)
Dec 1992
-
$145.10M(+41.8%)
Sep 1992
-
$102.30M(-9.0%)
Jun 1992
-
$112.40M(-19.3%)
Mar 1992
-
$139.20M(+76.9%)
Dec 1991
-
$78.70M(+1.7%)
Sep 1991
-
$77.40M(-49.9%)
Jun 1991
-
$154.50M(+14.3%)
Mar 1991
-
$135.20M(+21.7%)
Dec 1990
$111.09M(-69.9%)
$111.10M(+11.1%)
Sep 1990
-
$100.00M(+0.8%)
Jun 1990
-
$99.20M(+31.9%)
Mar 1990
-
$75.20M(-79.6%)
Dec 1989
$368.81M(+23.6%)
$368.80M(+371.0%)
Sep 1989
-
$78.30M(-68.5%)
Jun 1989
-
$248.60M(+273.8%)
Mar 1989
-
$66.50M(-77.7%)
Dec 1988
$298.35M(-12.7%)
$298.40M(-12.7%)
Dec 1987
$341.82M(+4.6%)
$341.80M(+4.6%)
Dec 1986
$326.78M(+7.3%)
$326.80M(+7.3%)
Dec 1985
$304.67M(+62.2%)
$304.70M(+62.2%)
Dec 1984
$187.82M(+2.8%)
$187.80M
Dec 1983
$182.78M(+49.4%)
-
Dec 1982
$122.37M(-22.1%)
-
Dec 1981
$157.02M(-9.6%)
-
Dec 1980
$173.65M
-

FAQ

  • What is CVS Health Corporation annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for CVS Health Corporation?
  • What is CVS Health Corporation annual cash & cash equivalents year-on-year change?
  • What is CVS Health Corporation quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for CVS Health Corporation?
  • What is CVS Health Corporation quarterly cash & cash equivalents year-on-year change?

What is CVS Health Corporation annual cash & cash equivalents?

The current annual cash & cash equivalents of CVS is $11.09B

What is the all time high annual cash & cash equivalents for CVS Health Corporation?

CVS Health Corporation all-time high annual cash & cash equivalents is $15.87B

What is CVS Health Corporation annual cash & cash equivalents year-on-year change?

Over the past year, CVS annual cash & cash equivalents has changed by -$457.00M (-3.96%)

What is CVS Health Corporation quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of CVS is $14.22B

What is the all time high quarterly cash & cash equivalents for CVS Health Corporation?

CVS Health Corporation all-time high quarterly cash & cash equivalents is $43.92B

What is CVS Health Corporation quarterly cash & cash equivalents year-on-year change?

Over the past year, CVS quarterly cash & cash equivalents has changed by -$2.10B (-12.87%)
On this page